Complementary and alternative medicine in multiple sclerosis: Survey of licensed naturopaths

Journal of Alternative and Complementary Medicine

Volumn 10, Issue 5, 2004, Pages 891-897

  Shinto, Lynne ^a   Calabrese, Carlo ^a   Morris, Cynthia ^a   Sinsheimer, Shannon ^a   Bourdette, Dennis ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ESSENTIAL FATTY ACID; MINERAL; VITAMIN;

ALTERNATIVE MEDICINE; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; HEALTH SURVEY; HERB; HOMEOPATHY; LABORATORY TEST; MULTIPLE SCLEROSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; REVIEW; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; HEALTH SURVEYS; HUMANS; LICENSURE; MULTIPLE SCLEROSIS; NATUROPATHY; OREGON; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME;

EID: 8644275680     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2004.10.891     Document Type: Review

References (32)

1. Bates D, Fawcett PR, Shaw DA, Weightman D. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. BMJ 1978:2:1390-1391.
2. Berkman C, Pignotti M, Cavallo P, Holland N. Use of alternative treatments by people with multiple sclerosis: Neurorehabilitation and Neural Repair 1999:13:243-254.
3. Calabrese C. Clinical research in naturopathic medicine. In: Lewith G, Jonas WB, Walach H, eds. Clinical Research in Complementary Therapies. Edinburgh: Churchill Livingstone, 2002: 345-362.
4. Calder PC. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997;41:203-234.
5. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002:61:345-358.
6. Dworkin RH, Bates D, Millar JH, Paty DW. Linoleic acid and multiple sclerosis: A reanalysis of three double-blind trials. Neurology 1984;34:1441-1445.
7. Filippini G, Munari L, Incorvaia B, Ebers GC, Polman C, D'Amico R, Rice GP. Interferons in relapsing remitting multiple sclerosis: A systematic review. Lancet 2003;361:545-552.
8. Gallai V, Sarchielli P, Trequattrini A, Murasecco D. Supplementation of polyunsaturated fatty acids in multiple sclerosis. Ital J Neural Sci 1992;13:401-407.
9. Hafler DA, Weiner HL. Immunologic mechanisms and therapy in multiple sclerosis. Immunol Rev 1995;144:75-107.
10. Hartung HP, Archelos JJ, Zielasek J, Gold R, Koltzenburg M, Reiners KH, Toyka KV. Circulating adhesion molecules and inflammatory mediators in demyelination: A review. Neurology 1995;45:S22-S32.
11. Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA. Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 1990;40:1735-1739.
12. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170:607-612.
13. Lauer K. Diet and multiple sclerosis. Neurology 1997;49:S55-S61.
14. Levin JS, Glass TA, Kushi LH, Schuck JR, Steele L, Jonas WB. Quantitative methods in research on complementary and alternative medicine: A methodological manifesto. NIH Office of Alternative Medicine. Med Care 1997;35:1079-1094.
15. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-187.
16. Millar JH, Zilkha KJ, Langman MJ, Wright HP, Smith AD, Belin J, Thompson RH. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J 1973;1:765-768.
17. Nahin RL, Straus SE. Research into complementary and alternative medicine: Problems and potential. BMJ 2001;322:161-164.
18. Nayak S, Matheis RJ, Schoenberger NE, Shiflett SC. Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil 2003;17:181-191.
19. Nordvik I, Myhr KM, Nyland H, Bjerve KS. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 2000;102:143-149.
20. Noseworthy J, Lucchinetti C, Rodriguez M, Weinshenker B. Multiple sclerosis. N Engl J Med 2000;343:938-952.
21. Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. The use of complementary and alternative therapies by people with multiple sclerosis. Chronic Dis Can 2003;24:75-79.
22. Paty DW, Cousin HK, Read S, Adlakha K. Linoleic acid in multiple sclerosis: Failure to show any therapeutic benefit. Acta Neurol Scand 1978;58:53-58.
23. Rudick RA, Ransohoff RM. Cytokine secretion by multiple sclerosis monocytes: Relationship to disease activity. Arch Neurol 1992:49:265-270.
24. Schwartz CE, Laitin E, Brotman S, LaRocca N. Utilization of unconventional treatments by persons with MS: Is it alternative or complementary? Neurology 1999;52:626-629.
25. Sharief MK, Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-472.
26. Shinto L, Calabrese C. Naturopathic therapies in neurology. In: Oken BS, ed. Complementary Therapies in Neurology: An Evidence-Based Approach. London: CRC Press-Parthenon Publishers, 2003:127-143.
27. Standish LJ, Greene K, Greenlee H, Kim JG, Grosshans C. Complementary and alternative medical treatment of breast cancer: A survey of licensed North American naturopathic physicians. Altern Ther Health Med 2002;8:68-75.
28. Swank R, Lerstad, O, Strom, A. Multiple sclerosis in rural Norway: Its geographic distribution and occupational incidence in relation to nutrition. N Engl J Med 1952;246:721-728.
29. Swank RL. Multiple sclerosis: Twenty years on low fat diet. Arch Neurol 1970;23:460-474.
30. Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990;336:37-39.
31. Trotter JL, Collins KG, van der Veen RC. Serum cytokine levels in chronic progressive multiple sclerosis: Interleukin-2 levels parallel tumor necrosis factor-alpha levels. J Neuroimmunol 1991;33:29-36.
32. Weinstock-Guttman B, Bayer M, Feichter J, Gallagher S. A randomized study of low fat diet with w-3 fatty acid supplementation in patients with relapsing remitting multiple sclerosis. Neurology 2003;60:A151.